GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Asset Turnover

Aroa Biosurgery (ASX:ARX) Asset Turnover : 0.33 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Aroa Biosurgery's Revenue for the six months ended in Mar. 2024 was A$34.38 Mil. Aroa Biosurgery's Total Assets for the quarter that ended in Mar. 2024 was A$103.24 Mil. Therefore, Aroa Biosurgery's Asset Turnover for the quarter that ended in Mar. 2024 was 0.33.

Asset Turnover is linked to ROE % through Du Pont Formula. Aroa Biosurgery's annualized ROE % for the quarter that ended in Mar. 2024 was -8.78%. It is also linked to ROA % through Du Pont Formula. Aroa Biosurgery's annualized ROA % for the quarter that ended in Mar. 2024 was -7.54%.


Aroa Biosurgery Asset Turnover Historical Data

The historical data trend for Aroa Biosurgery's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Asset Turnover Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
- 0.26 0.42 0.56 0.60

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Asset Turnover Get a 7-Day Free Trial 0.19 0.25 0.32 0.27 0.33

Competitive Comparison of Aroa Biosurgery's Asset Turnover

For the Medical Devices subindustry, Aroa Biosurgery's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aroa Biosurgery's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Asset Turnover falls into.



Aroa Biosurgery Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Aroa Biosurgery's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=63.357/( (109.071+101.878)/ 2 )
=63.357/105.4745
=0.60

Aroa Biosurgery's Asset Turnover for the quarter that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=34.382/( (104.592+101.878)/ 2 )
=34.382/103.235
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Aroa Biosurgery  (ASX:ARX) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Aroa Biosurgery's annulized ROE % for the quarter that ended in Mar. 2024 is

ROE %**(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-7.782/88.6715
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-7.782 / 68.764)*(68.764 / 103.235)*(103.235/ 88.6715)
=Net Margin %*Asset Turnover*Equity Multiplier
=-11.32 %*0.6661*1.1642
=ROA %*Equity Multiplier
=-7.54 %*1.1642
=-8.78 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2024) net income data. The Revenue data used here is two times the semi-annual (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Aroa Biosurgery's annulized ROA % for the quarter that ended in Mar. 2024 is

ROA %(Q: Mar. 2024 )
=Net Income/Total Assets
=-7.782/103.235
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-7.782 / 68.764)*(68.764 / 103.235)
=Net Margin %*Asset Turnover
=-11.32 %*0.6661
=-7.54 %

Note: The Net Income data used here is two times the semi-annual (Mar. 2024) net income data. The Revenue data used here is two times the semi-annual (Mar. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Aroa Biosurgery Asset Turnover Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines